头颈癌患者质子放疗后下颌骨放射性骨坏死
这项单中心病例系列纳入2013年11月至2019年9月在纪念斯隆-凯特琳癌症中心接受质子放疗的122例初治口腔及口咽癌患者,中位随访40.6个月,13例(10.6%)发生下颌骨放射性骨坏死,均为自发发生,最常见的部位为照射野内接受全量质子放疗的同侧下颌骨后部;3年和5年放射性骨坏死发生率分别为5.2%和11.5%,死亡率分别为21.5%和34.4%。作者认为即使在高适形质子放疗时代,放射性骨坏死仍是临床挑战,治疗口腔及口咽癌的临床医生应警惕此并发症。
要点
- 122例口腔及口咽癌患者质子放疗后中位随访40.6个月,13例(10.6%)发生下颌骨放射性骨坏死。
- 13例放射性骨坏死均为自发发生,最常见于照射野内接受全量质子放疗的同侧下颌骨后部。
- 全队列3年放射性骨坏死率为5.2%、死亡率为21.5%,5年分别为11.5%和34.4%。
核心结论
- 该病例系列中质子放疗后下颌骨放射性骨坏死发生率为10.6%,提示即使在高适形质子放疗时代放射性骨坏死仍是临床挑战。
- 作者认为治疗口腔及口咽癌并采用质子放疗的临床医生应警惕这一并发症。
研究设计与样本
- 单中心病例系列,报告2013年11月至2019年9月纪念斯隆-凯特琳癌症中心(纽约)122例接受质子放疗的初治口腔及口咽癌患者的经验。
- 数据分析时间为2013年至2019年。
主要发现
- 122例患者平均(SD)年龄63(13)岁,女性45例(36.9%)、男性77例(63.1%)。
- 中位(范围)随访40.6(<1-101)个月期间,13例(10.6%)发生放射性骨坏死,均为自发发生。
- 初诊时放射性骨坏死0级、1级、2级、3级分别为2例、1例、9例、1例。
- 最常见的放射性骨坏死部位为照射野内接受全量计划质子放疗的同侧下颌骨后部。
- 自放射性骨坏死诊断起中位(范围)随访13.5(0.2-58.0)个月,放射性骨坏死完全缓解、稳定、进展分别为3例、6例、4例。
关键数值与推荐
- 放射性骨坏死的临床或影像学征象采用改良Glanzmann和Grätz分级系统进行识别和分级。
临床怎么用
- 作者认为治疗口腔及口咽癌并采用质子放疗的临床医生应警惕放射性骨坏死这一并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Proton radiation therapy (PRT) has reduced radiation-induced toxic effects, such as mucositis and xerostomia, over conventional photon radiation therapy, leading to significantly improved quality of life in patients with head and neck cancers. However, the prevalence of osteoradionecrosis (ORN) of the jaw following PRT in these patients is less clear. OBJECTIVE: To report the prevalence and clinical characteristics of ORN in patients with oral and oropharyngeal cancer (OOPC) treated with PRT. DESIGN, SETTING, AND PARTICIPANTS: This case series reports a single-institution experience (Memorial Sloan Kettering Cancer Center, New York, New York) between November 2013 and September 2019 and included 122 radiation therapy-naive patients with OOPC treated with PRT. Data were analyzed from 2013 to 2019. MAIN OUTCOMES AND MEASURES: Clinical parameters, including sex, age, comorbidities, tumor histology, concurrent chemotherapy, smoking, comorbidities, and preradiation dental evaluation, were obtained from the medical record. Patients with clinical or radiographic signs of ORN were identified and graded using the adopted modified Glanzmann and Grätz grading system. Characteristics of ORN, such as location, clinical presentation, initial stage at diagnosis, etiology, time to diagnosis, management, and clinical outcome at the last follow-up, were also collected. RESULTS: Of the 122 patients (mean [SD] age, 63 [13] years; 45 [36.9%] women and 77 [63.1%] men) included in this study, 13 (10.6%) developed ORN following PRT during a median (range) follow-up time of 40.6 (<1-101) months. All patients had spontaneous development of ORN. At the time of initial diagnosis, grade 0, grade 1, grade 2, and grade 3 ORN were seen in 2, 1, 9, and 1 patient, respectively. The posterior ipsilateral mandible within the radiation field that received the full planned PRT dose was the most involved ORN site. At a median (range) follow-up of 13.5 (0.2-58.0) months from the time of ORN diagnosis, complete resolution, stable condition, and progression of ORN were seen in 3, 6, and 4 patients, respectively. The 3-year rates of ORN and death in the total cohort were 5.2% and 21.5%, while the 5-year rates of ORN and death were 11.5% and 34.4%, respectively. CONCLUSIONS AND RELEVANCE: In this case series, the prevalence of ORN following PRT was found to be 10.6%, indicating that ORN remains a clinical challenge even in the era of highly conformal PRT. Clinicians treating patients with OOPC with PRT should be mindful of this complication.
引用
- Singh A, Kitpanit S, Neal B, et al. Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36547968. doi:10.1001/jamaoto.2022.4165
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。